We found for
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![Value, Access, and Incentives for Innovation - Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/wp-content/uploads/2019/03/Value-Access-and-Incentives-for-Innovation-Policy-Perspectives-on-Alternative-Models-for-Pharmaceutical-Rebates.jpg)
How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?
![How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?](https://www.ohe.org/wp-content/uploads/2016/08/Panel1.jpg)
A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications
![A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications](https://www.ohe.org/wp-content/uploads/2016/05/Front-Page-NICE-HTA-methods-RP-FINAL_0.gif)
Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
![408 - Respondent hypothetical priority-setting exercises and policy implications](https://www.ohe.org/wp-content/uploads/2015/02/408-Respondent-hypothetical-priority-setting-exercises-and-policy-implications.jpg)
- 01
- 02